Nonsteroidal Anti-Inflammatory Drugs, Alone or Combined With Opioids, for Cancer Pain

医学 安慰剂 类阿片 癌症疼痛 止痛药 药品 临床试验 内科学 非甾体 药理学 癌症 病理 受体 替代医学
作者
Ewan D McNicol,Scott A. Strassels,Leonidas C. Goudas,Joseph Lau,Daniel B. Carr
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:22 (10): 1975-1992 被引量:135
标识
DOI:10.1200/jco.2004.10.524
摘要

PURPOSE: To assess the safety and efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs), alone or combined with opioids, for the treatment of cancer pain. PATIENTS AND METHODS: Forty-two trials involving 3,084 patients met inclusion criteria: eight compared NSAID with placebo; 13 compared one NSAID with another; 23 compared NSAID with opioid, NSAID or opioid versus NSAID plus opioid combinations, or NSAID plus opioid combinations versus NSAID plus opioid combinations; and nine studies assessed the effect of increasing NSAID dose. RESULTS: Sixteen studies lasted 1 week or longer and 11 evaluated a single dose. Seven of eight trials demonstrated superior efficacy of single doses of NSAID compared with placebo. Only four of 13 studies reported increased efficacy of one NSAID compared with another; four other studies found that one NSAID had fewer side effects than one or more others. Thirteen of 14 studies found no difference, or minimal clinical difference, when comparing an NSAID plus opioid combination versus either drug alone. Comparisons between various NSAID plus opioid combinations were inconclusive. Four studies demonstrated increased efficacy with increased NSAID dose, without dose-dependent increases in side effects. CONCLUSION: Heterogeneity of study methods and outcomes precluded meta-analyses. Short duration of studies undermines generalization of findings on efficacy and safety. On the basis of limited data, NSAIDs appear to be more effective than placebo for cancer pain; clear evidence to support superior safety or efficacy of one NSAID compared with another is lacking; and trials of combinations of an NSAID with an opioid have disclosed either no significant difference, or at most a slight but statistically significant advantage, compared with either single entity.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
田様的应助被yght采纳,获得10
1秒前
1秒前
南屿完成签到,获得积分10
1秒前
脑洞疼的应助被大风采纳,获得10
2秒前
zjl完成签到,获得积分10
2秒前
2秒前
2秒前
lzj完成签到 ,获得积分10
2秒前
风的味道发布了新的文献求助10
2秒前
2秒前
乐乐的应助被keyan_xiaojiang采纳,获得10
2秒前
丨丨丨完成签到,获得积分10
2秒前
向浏岚发布了新的文献求助10
3秒前
尹相汛发布了新的文献求助10
3秒前
Youdge的应助被来一杯忌廉采纳,获得30
3秒前
3秒前
刘世敏完成签到,获得积分10
3秒前
杰杰小杰发布了新的文献求助10
3秒前
南屿发布了新的文献求助10
4秒前
Orange的应助被XiYang采纳,获得10
5秒前
xxddbb完成签到,获得积分10
6秒前
Udb完成签到,获得积分20
6秒前
6秒前
酷波er的应助被勤劳的星月采纳,获得10
7秒前
7秒前
7秒前
WuX发布了新的文献求助10
8秒前
Tangxianfeng发布了新的文献求助10
8秒前
8秒前
9秒前
高挑的向南完成签到,获得积分10
9秒前
传奇3的应助被标致书易采纳,获得10
10秒前
win7完成签到,获得积分10
10秒前
10秒前
2499297293发布了新的文献求助10
10秒前
10秒前
狂野的高山完成签到,获得积分10
10秒前
mingxing818完成签到,获得积分10
11秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175556
求助须知:如何正确求助?哪些是违规求助? 9567240
关于积分的说明 21791502
捐赠科研通 7770174
什么是DOI,文献DOI怎么找? 3431868
关于科研通互助平台的介绍 2556244
邀请新用户注册赠送积分活动 2477299